Filing Details

Accession Number:
0001209191-20-052511
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-30 19:03:09
Reporting Period:
2020-09-28
Accepted Time:
2020-09-30 19:03:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557533 Robert Jeffrey Ajer 105 Digital Drive
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-09-28 3,250 $17.25 25,975 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Represents the number of shares sold by the reporting person to cover tax obligations in connection with the vesting of restricted stock units.
  3. This transaction was executed in multiple trades at prices ranging from $17.06 to $17.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.